These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 19622007

  • 1. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.
    Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
    [Abstract] [Full Text] [Related]

  • 2. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
    Handelsman Y, Abby SL, Jin X, Donovan JM, Jones MR.
    Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 4. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
    Goldfine AB, Fonseca VA, Jones MR, Wang AC, Ford DM, Truitt KE.
    Horm Metab Res; 2010 Jan 28; 42(1):23-30. PubMed ID: 19862667
    [Abstract] [Full Text] [Related]

  • 5. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE, Davidson M, Jones MR, Abby SL.
    Am J Cardiol; 2006 Apr 15; 97(8):1198-205. PubMed ID: 16616026
    [Abstract] [Full Text] [Related]

  • 6. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P.
    Metab Syndr Relat Disord; 2010 Dec 15; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [Abstract] [Full Text] [Related]

  • 7. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L, Hermes-Desantis ER.
    Ann Pharmacother; 2010 Dec 15; 44(7-8):1196-206. PubMed ID: 20551301
    [Abstract] [Full Text] [Related]

  • 8. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H, Rhyne J, Abby S, Lai YL, Jones M.
    Curr Med Res Opin; 2006 Nov 15; 22(11):2191-200. PubMed ID: 17076980
    [Abstract] [Full Text] [Related]

  • 9. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan 15; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 10. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin.
    Kadhim HM, Ismail SH, Hussein KI, Bakir IH, Sahib AS, Khalaf BH, Hussain SA.
    J Pineal Res; 2006 Sep 15; 41(2):189-93. PubMed ID: 16879326
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
    Brunetti L, Campbell RK.
    J Pharm Pract; 2011 Aug 15; 24(4):417-25. PubMed ID: 21813819
    [Abstract] [Full Text] [Related]

  • 12. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE.
    Endocr Pract; 2011 Aug 15; 17(6):933-8. PubMed ID: 21856592
    [Abstract] [Full Text] [Related]

  • 13. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE, Goldberg RB, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Oct 13; 168(18):1975-83. PubMed ID: 18852398
    [Abstract] [Full Text] [Related]

  • 14. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G, Hancu N.
    Horm Metab Res; 2009 Feb 13; 41(2):116-22. PubMed ID: 19214921
    [Abstract] [Full Text] [Related]

  • 15. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.
    Clin Ther; 2007 Jan 13; 29(1):74-83. PubMed ID: 17379048
    [Abstract] [Full Text] [Related]

  • 16. Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2 diabetic patients.
    Yang J, Di F, He R, Zhu X, Wang D, Yang M, Wang Y, Yuan S, Chen J.
    Chin Med J (Engl); 2003 May 13; 116(5):785-7. PubMed ID: 12875702
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
    Knopp RH, Tsunehara C, Retzlaff BM, Fish B, Nguyen H, Anderson S, Nguyen T.
    Metabolism; 2006 Dec 13; 55(12):1697-703. PubMed ID: 17142146
    [Abstract] [Full Text] [Related]

  • 18. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
    Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR.
    Diabetes Care; 2008 Aug 13; 31(8):1479-84. PubMed ID: 18458145
    [Abstract] [Full Text] [Related]

  • 19. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR, Hagan MA.
    Pharmacoeconomics; 2010 Aug 13; 28(9):765-80. PubMed ID: 20799756
    [Abstract] [Full Text] [Related]

  • 20. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC.
    Drugs Aging; 2012 May 01; 29(5):e1-e12. PubMed ID: 22530704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.